J Matthew Wood Selected Research

pyridazine

7/2023	Correction to "Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models".
1/2019	Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models.
4/2013	Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Matthew Wood Research Topics

Disease

2	Neoplasms (Cancer) 07/2023 - 01/2019
1	Type 2 Diabetes Mellitus (MODY) 09/2023
1	Prostatic Neoplasms (Prostate Cancer) 04/2013
1	Obesity 06/2012

Drug/Important Bio-Agent (IBA)

3	pyridazineIBA 07/2023 - 04/2013
2	GlutaminaseIBA 07/2023 - 01/2019
2	ThiadiazolesIBA 07/2023 - 01/2019
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 09/2023
1	Glutamine (L-Glutamine)FDA Link 01/2019
1	AmidohydrolasesIBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	PiperazineIBA 04/2013
1	AZD3514IBA 04/2013
1	NitrogenIBA 04/2013
1	Androgen Receptors (Androgen Receptor)IBA 04/2013
1	OxadiazolesIBA 06/2012